Immunic Inc

NASDAQ:IMUX   4:00:00 PM EDT
1.21
-0.07 (-5.47%)
7:58:01 PM EDT: $1.23 +0.02 (+1.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunic Inc Stock, NASDAQ:IMUX

1200 Avenue of the Americas, Suite 200, New York, New York 10036
United States of America
Phone: +1.332.255.9818
Number of Employees: 77
http://www.immunic-therapeutics.com

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn�s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm�s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.